X4 Pharmaceuticals, Inc.

NasdaqCM:XFOR Stock Report

Market Cap: US$171.3m

X4 Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 2/6

X4 Pharmaceuticals has a total shareholder equity of $1.0M and total debt of $54.8M, which brings its debt-to-equity ratio to 5291.9%. Its total assets and total liabilities are $112.2M and $111.1M respectively.

Key information

5,291.9%

Debt to equity ratio

US$54.82m

Debt

Interest coverage ration/a
CashUS$80.87m
EquityUS$1.04m
Total liabilitiesUS$111.15m
Total assetsUS$112.18m

Recent financial health updates

Recent updates

Is X4 Pharmaceuticals (NASDAQ:XFOR) Weighed On By Its Debt Load?

Mar 26
Is X4 Pharmaceuticals (NASDAQ:XFOR) Weighed On By Its Debt Load?

Is X4 Pharmaceuticals (NASDAQ:XFOR) A Risky Investment?

Apr 19
Is X4 Pharmaceuticals (NASDAQ:XFOR) A Risky Investment?

Is X4 Pharmaceuticals (NASDAQ:XFOR) Using Too Much Debt?

Oct 07
Is X4 Pharmaceuticals (NASDAQ:XFOR) Using Too Much Debt?

X4 Pharmaceuticals: Upcoming Catalysts

Sep 19

X4 Pharma to focus resources on lead drug candidate, cut workforce by about 20%

Jul 20

X4 Pharmaceuticals to raise $55M in stock and warrants offering, debt facility amended

Jul 01

X4 Pharma: Late Stage Nanocap Targeting Rare Diseases

Aug 03

Is X4 Pharmaceuticals (NASDAQ:XFOR) Using Debt Sensibly?

Jun 22
Is X4 Pharmaceuticals (NASDAQ:XFOR) Using Debt Sensibly?

X4 Pharmaceuticals EPS misses by $0.44

May 06

How Many X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Shares Do Institutions Own?

Mar 16
How Many X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Shares Do Institutions Own?

X4 Pharmaceuticals EPS misses by $0.12

Nov 05

Financial Position Analysis

Short Term Liabilities: XFOR's short term assets ($87.3M) exceed its short term liabilities ($23.5M).

Long Term Liabilities: XFOR's short term assets ($87.3M) do not cover its long term liabilities ($87.6M).


Debt to Equity History and Analysis

Debt Level: XFOR has more cash than its total debt.

Reducing Debt: XFOR's debt to equity ratio has increased from 63.4% to 5291.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: XFOR has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: XFOR has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.1% each year


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.